Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ha, nice Cervelo, I was trying to paint a picture , and I can definitely relate!
Bam, slim out of the gates, like a freshly de- nut-ed bull!!
Hats off to Jess,I recall that post.
Agreed, Dia, good post
I think we should refer to the GF as “The Cooler”
CNBC HALFTIME REPORT analysts purchased INO today’s show.
As always, I second that slim.
As always, I second that slim.
SRNE will pop when everybody least expects it, then deciding when and how much to sell will be the big dilemma.
H.C. Wainwright lifts Sorrento Therapeutics Inc. [SRNE] price estimate. Who else is bullish?
Me
Slim, I’m a bit jealous here, sounds like your wife has my dream job, getting paid to see “lots of woman”.
Dia, you’re en fuego,thanks dude!
Agreed Jess and I’m sure you remember - as many people on this board do and many thought he was absolutely nuts for saying- but Ji was one of the first, if not the first scientist to publicly claim that neutralizing the antibodies would be the quickest way to fight the virus.
The Streets (Jim Cramer) website posted this right after the interview with Ji.This is an extremely positive review.
https://www.thestreet.com/jim-cramer/stimulus-and-covid-cramers-mad-money-recap-oct-15
My point is, this is a five star analyst with a huge brokerage firm asking the tough questions and still not lowering his PT of $30. Further proof, the shorts and the uninformed were doing the selling.I’ll bet a ton of people who sold weren’t even on the call.
Dia, Jess, Q, all of you were on the call Tuesday right..
If so, did you here Ram from Wainwright asking a bunch of really solid questions to Ji?
He still has a $30 price target for SRNE.
Great post Jess,
Cramer hinted SRNE is a buy, did you catch that Dom?
Great news Dia, and the 8-k form shows the duration of the test.
Hilarious Jess! I think some “investors” thought Ji was going to wear his underwear outside of his leotards with a big S on his chest and a red cape announcing “I have the vaccine in my pocket”
Right on the money Dia, as usual!
I’m with Jess on this, I consider that call to be exceptional compared to the ones in the past. The shorts sold on the news, SRNE will be back up tomorrow.
Good stuff so far Q!!
Good job Dom
Who’s all jumping on the call today, Jess, you in?
You still paid under $3, Slim, again it’s a long term play, but I think a no brainer.
Jess, I know it can be frustrating, but you have to remember, SRNE was largely a pain management/ cancer play when Covid came along.SRNE doesn’t have the reputation and resources of a big pharma company so they constantly have to prove themselves. Ji made some bold statements and lost a lot of respect for dumping his CFO without explanation and the market is getting bearish on this behavior, just think of INO..The truth is , you have to believe in Ji to stay long, which can be trying, if your really in doubt, maybe ring the register on half of your position since most of us got in at $4.I’m holding long though and agree with Q on this as a long term play with a potential Covid pop in the near future.
Amen Jess, check out my reply to Slim.
I agree completely Slim, well said!
I brought a couple thousand shares of SUVRF @1.15 roughly 3 months ago when they came public. I wanted to buy more but didn’t because it’s currently a grey market stock in the US and lacks liquidity. For me it’s a long term play and I believe from the PR’s along with contacting the company directly that when they penetrate the American markets, the stock will blow up.They plan on coming to the US , then combing the two ticker symbols to one NASDAQ ticker.I shared the info with you guys on the AUPH board because you seem like righteous people for the most part and I have been long with AUPH.
You’ll love this the most Slim... if you contact them, they get to you immediately with clear concise feedback.
Good post Don!
Great point Moose, this is a Canadian company, listed as MEAT.CN on the CSE., it’s traded under SUVRF here in the states.they just went public roughly 3 months ago.184k trades today for MEAT and and a mere 3.3k for SUV. This is a LONG TERM play and very little liquidity currently.I’m a huge carnivore, but I see this as a Canadian Beyond meat, there’s just too much potential.
It’s about time we got a decent article, this is just the beginning!
Slim, Jess, Cervelo, Greg, I know we talked about this a few months ago, check out SUVRF,it’s doubled since I recommended it, and it’s just getting started. Read the PR’s, textbook rollout for success.
Word Q
Right on Zep!
News today,pretty much what the CFO told me ...
Cassava Sciences is currently conducting a long-term, open-label, multi-center study of sumifilam 100 mg twice-daily for 12 months. The study's target enrollment is approximately 100 patients with mild-to-moderate Alzheimer's disease. This study is over 50% enrolled.
Janga, this company is ripe for a buyout !!
Great question newbie,
I believe we’ll be in the mid-high twenties by the end of December, then 30-40 by February. After that, I think we’ll see the 50-60 range in either PPS or buyout. BUT I would not be surprised if Jess was right about 80’s plus, especially if we have a vaccine by then.
Excellent point Q, we need several testing kits, Abbot can’t keep up with the demand, and competition will help all involved.
Agreed, and when that happens grab your ass and glass to celebrate!